This article has been archived.
Please use for reference only.
Abramson Cancer Center of the University of Pennsylvania
Last Modified: July 20, 2007
On demand video of the "IBA Proton Therapy Symposium" from the 2007 San Francisco Radiation Oncology Conference. International cancer experts give you an exclusive opportunity to learn and share the information on the most recent developments in Proton Therapy. Tune in now to experience the collected knowledge of:
Jay Loeffler, M.D. Chief of Radiation Oncology at Burr Proton Therapy Center "Is proton therapy experimental?"
Nancy Tarbell, M.D. CC Wang Professor of Radiation Oncology at Burr Proton Therapy Center "Proton Radiation in Pediatric Solid Tumors"
Carlos Vargas, M.D. at the University of Florida Proton Therapy Institute "Image Guided Proton Prostate Cancer Therapy"
James Metz, M.D. Chief of Clinical Operations at the University of Pennsylvania "The Decision Process for Proton Therapy at the University of Pennsylvania "
Dec 21, 2014 - Long-term survival may be increased in medium-risk prostate cancer patients who receive short-term androgen deprivation therapy before and during radiation treatment compared with men who receive radiation alone. In addition, proton beam therapy may be associated with a decreased risk of disease recurrence after 10 years and has minimal side effects after one year, according to research presented at the 51st Annual Meeting of the American Society for Radiation Oncology, held from Nov. 1 to 5 in Chicago.